Literature DB >> 34022361

Gene expression profile and long noncoding RNA analysis in Candida albicans insoluble β-glucan-stimulated CD14+ monocytes and THP-1 cells.

Jun-Sheng Hou1, Yan-Yan He2, Lei-Lei Du3, Zhi-Min Duan4, Xu Chen5, Min Li6.   

Abstract

Emerging evidence suggests that long noncoding RNAs (lncRNAs) play important roles in disease development. However, the roles of lncRNAs in the pathogenesis of Candida albicans (C. albicans) remain unclear. Our study aimed to investigate and characterize the mRNA and lncRNA transcriptomes of CD14+ monocytes and THP-1 cells stimulated with insoluble β-glucan by RNA-seq. We identified a total of 10788 differentially expressed (DE) mRNAs and 2021 DE lncRNAs in CD14+ monocytes, while 3349 DE mRNAs and 291 DE lncRNAs were observed in THP-1 cells. A total of 808 DE mRNAs and 51 DE lncRNAs overlapped between the two groups. We examined five collectively DE mRNAs and lncRNAs in both cells using quantitative real-time PCR, validating the reliability of the RNA-seq results. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses revealed that the 808 DE mRNAs were mostly enriched in the inflammatory response and NF-kappa B signaling pathway, respectively. Next, lncRNA-mRNA coexpression analysis was performed for the 51 DE lncRNAs and the 808 DE mRNAs in the two groups. We chose the common network pairs of the two groups to construct the coexpression network and revealed 97 network pairs comprising 8 dysregulated lncRNAs and 60 dysregulated mRNAs. We found that lncRNA lnc-CCL3L3-1:1 might be involved in the NF-kappa B signaling pathway in C. albicans infection. In conclusion, the aberrantly expressed lncRNAs might play a role in the pathogenesis of C. albicans infection and could be used as therapeutic targets in the future.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Candida albicans; Long noncoding RNA; Monocytes/macrophages; RNA-seq; β-glucan

Mesh:

Substances:

Year:  2021        PMID: 34022361     DOI: 10.1016/j.micpath.2021.104963

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  2 in total

1.  Evaluation of an RNAseq-Based Immunogenomic Liquid Biopsy Approach in Early-Stage Prostate Cancer.

Authors:  Leander Van Neste; Kirk J Wojno; Ricardo Henao; Shrikant Mane; Howard Korman; Jason Hafron; Kenneth Kernen; Rima Tinawi-Aljundi; Mathew Putzi; Amin I Kassis; Philip W Kantoff
Journal:  Cells       Date:  2021-09-28       Impact factor: 6.600

Review 2.  LncRNA: A Potential Target for Host-Directed Therapy of Candida Infection.

Authors:  Ye Wang; Hongdan Xu; Na Chen; Jin Yang; Hongmei Zhou
Journal:  Pharmaceutics       Date:  2022-03-11       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.